Pwognostik maladi sik varye selon kalite maladi sik la ak jan yo jere l byen.
Dyabèt tip 1 se yon maladi otoiminitè kote kò a pa pwodui ensilin, epi li mande terapi ensilin pou tout lavi.
Avèk bon jan jesyon, ki gen ladan piki ensilin, rejim alimantè ki an sante, ak egzèsis regilye, moun ki gen dyabèt tip 1 ka viv lontan ak an sante.
Sepandan, si nou pa pran bon swen, sa ka lakòz pwoblèm tankou maladi kè, maladi ren, pwoblèm nè ak pwoblèm nan je.
Dyabèt tip 2 se rezistans ensilin ki lakòz li e souvan li asosye avèk faktè fòm tankou obezite ak mank aktivite fizik.
Avèk bon jan jesyon, ki gen ladan medikaman, rejim alimantè, ak egzèsis, moun ki gen dyabèt tip 2 ka amelyore kontwòl sik nan san yo epi redwi risk konplikasyon yo.
Nan kèk ka, yo ka menm fè moun ki gen dyabèt tip 2 la pèdi pwa e yo ka chanje fason yo viv.
Dyabèt gwosès rive pandan gwosès la epi li nòmalman disparèt apre akouchman an.
Sepandan, fanm ki gen dyabèt pandan gwosès yo gen plis chans pou yo vin gen dyabèt tip 2 pi devan.
An jeneral, pwognostik pou dyabèt bon si li jere kòrèkteman, men li enpòtan pou travay kole kole ak yon ekip swen sante pou kontwole nivo sik nan san epi fè chanjman nesesè nan fason pou viv pou anpeche konplikasyon.
Zhao XB, Ren GS: Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016, 95 (49): e5602.
Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998, 27 (6): 1567-71.
Pallisgaard JL, Lindhardt TB, Olesen JB, Hansen ML, Carlson N, Gislason GH: Management and prognosis of atrial fibrillation in the diabetic patient. Expert Rev Cardiovasc Ther. 2015, 13 (6): 643-51.
Borch-Johnsen K: [Insulin-dependent diabetes mellitus--improved prognosis and insurance outlook]. Nord Med. 1992, 107 (8-9): 217-9.
Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Tanikawa M, Sone Y, Hisanaga Y: Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001, 91 (5): 957-63.
Gao RZ, Gu J, Du CZ, Li M: [Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.]. Zhonghua Wai Ke Za Zhi. 2010, 48 (2): 88-92.
['Avètisman: medikal']
['Sit entènèt sa a se pou rezon edikasyonèl ak enfòmasyon sèlman e li pa bay konsèy medikal oswa sèvis pwofesyonèl.']
['Enfòmasyon yo bay la pa dwe itilize pou fè dyagnostik oswa trete yon pwoblèm sante oswa maladi, e moun k ap chèche konsèy medikal pèsonèl ta dwe konsilte yon doktè ki gen lisans.']
['Tanpri note ke rezo neural ki jenere repons pou kesyon yo, pa egzat sitou lè li rive pou kontni nimerik. pa egzanp, kantite moun ki te dyagnostike ak yon maladi espesifik.']
['Toujou chèche konsèy doktè ou oswa lòt founisè sante ki kalifye konsènan yon kondisyon medikal. Pa janm meprize konsèy medikal pwofesyonèl oswa reta nan chèche li paske nan yon bagay ou te li sou sit entènèt sa a. Si ou panse ou ka gen yon ijans medikal, rele 911 oswa ale nan sal ijans ki pi pre a imedyatman. Pa gen okenn relasyon doktè-pasyan ki kreye pa sit entènèt sa a oswa itilizasyon li yo. Ni BioMedLib ni anplwaye li yo, ni okenn kontribitè nan sit entènèt sa a, fè okenn reprezantasyon, eksprime oswa enplisit, ki gen rapò ak enfòmasyon yo bay isit la oswa pou itilize li yo.']
['Avètisman: dwa otè']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) bay rekou pou mèt copyright ki kwè ke materyèl ki parèt sou entènèt la vyole dwa yo anba lwa copyright Etazini. ']
['Si ou kwè ak tout konfyans ke nenpòt kontni oswa materyèl ki disponib an koneksyon avèk sit entènèt nou an oswa sèvis vyole copyright ou, ou (oswa ajan ou) ka voye nou yon avi pou mande pou retire kontni an oswa materyèl la, oswa aksè a li bloke.']
['Anons yo dwe voye alekri pa imel (gade seksyon "Kontak" pou adrès imel)']
['DMCA mande pou avi ou sou vyolasyon dwa otè a genyen enfòmasyon sa yo: (1) deskripsyon travay ki gen dwa otè a ki sijè vyolasyon an; (2) deskripsyon kontni ki vyole dwa otè a ak enfòmasyon ki sifi pou pèmèt nou jwenn kontni an; (3) enfòmasyon pou kontakte ou, ki gen ladan adrès ou, nimewo telefòn ou ak adrès imel ou; (4) yon deklarasyon ou fè ki di ou gen bon lafwa ke kontni an nan fason ou pote plent la pa otorize pa mèt pwopriyete dwa otè a, oswa ajan li, oswa pa operasyon nenpòt lwa; ']
['(5) yon deklarasyon ou siyen sou penalite fo temwayaj ke enfòmasyon ki nan notifikasyon an egzat e ke ou gen otorite pou fè respekte dwa otè yo ke yo reklame ke yo vyole yo;']
['e (6) yon siyati fizik oubyen elektwonik mèt copyright la oubyen yon moun ki otorize pou aji sou non mèt copyright la. ']
['Si ou pa bay tout enfòmasyon ki anwo yo, sa ka fè ke nou pa trete plent ou a byen vit.']
['Kontak']
['Tanpri voye nou yon imèl avèk nenpòt kesyon / sijesyon.']
What is prognosis of diabetes?
The prognosis of diabetes varies depending on the type of diabetes and how well it is managed.
Type 1 diabetes is an autoimmune disease where the body does not produce insulin, and it requires lifelong insulin therapy.
With proper management, including insulin injections, healthy diet, and regular exercise, individuals with type 1 diabetes can lead long and healthy lives.
However, if not managed properly, it can lead to complications such as heart disease, kidney disease, nerve damage, and eye problems.
Type 2 diabetes is caused by insulin resistance and is often associated with lifestyle factors such as obesity and lack of physical activity.
With proper management, including medication, diet, and exercise, individuals with type 2 diabetes can improve their blood sugar control and reduce the risk of complications.
In some cases, type 2 diabetes can even be reversed through significant weight loss and lifestyle changes.
Gestational diabetes occurs during pregnancy and usually resolves after delivery.
However, women with gestational diabetes have an increased risk of developing type 2 diabetes later in life.
Overall, the prognosis for diabetes is good if it is managed properly, but it is important to work closely with a healthcare team to monitor blood sugar levels and make necessary lifestyle changes to prevent complications.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['sou']
['BioMedLib itilize òdinatè otomatik (algoritm aprantisaj machin) pou jenere pè kesyon ak repons.']
['Nou kòmanse ak 35 milyon piblikasyon biomedik de PubMed/Medline. tou, paj entènèt de RefinedWeb.']
